Please enter your username or email address. You will receive a link to create a new password via email.
© 2023 MergersCorp M&A International. is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://www.mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.
This website is operated by MergersUS Inc.a US Corporation with registered office at 40th Wall Street, Suite #2725, New York, New York 10005, United States of America.
This Ethical Pharmaceutical Manufacturing Company was established 30 years ago in India. The company has two business units: Contract Manufacturing and Own Branded Marketing.
The manufacturing facilities are State of Art WHO- GMP and ISO 9001:2008 Certified Manufacturing facilities.
The company is in charge for the production of Tablets and Capsules in Cefa and General Blocks with a Dedicated Ointments Plant. It has a capacity to produce 150 Million Caps/tabs/month. Currently there are 40 brands produced. The Ointments division has a capacity to produce 15 Lakh tubes/month.
The company produce various products under 50 brands name: Pain Management, Nutraceutical, Anti-Bacterial, Anti-Diabetic, Anti-hypertensive Neurological, etc.
Gross Revenue
$7,538,000
EBITDA
TBA
Business ID:
L#20220340
Country
India
Business ID: | L#20220340 |
Property Type: | Manufacturing, Pharma |
Property Status: | For Sale |
Target Price: | $10,000,000 |
Gross Revenue: | $7,538,000 |
EBITDA: | TBA |
Target Price / Revenue: | 1.33x |
Target Price / EBITDA: | INFx |
Reason for Selling: | The reason for sale is succession issue as the founder is old and both his sons are settled in US . |
Updated on August 31, 2022 at 7:52 am
$1,000,000
Manufacturing
This Ethical Pharmaceutical Manufacturing Company was established 30 years ago in India. The company has two business units: Contract Manufacturing and Own Branded Marketing.
The manufacturing facilities are State of Art WHO- GMP and ISO 9001:2008 Certified Manufacturing facilities.
The company is in charge for the production of Tablets and Capsules in Cefa and General Blocks with a Dedicated Ointments Plant. It has a capacity to produce 150 Million Caps/tabs/month. Currently there are 40 brands produced. The Ointments division has a capacity to produce 15 Lakh tubes/month.
The company produce various products under 50 brands name: Pain Management, Nutraceutical, Anti-Bacterial, Anti-Diabetic, Anti-hypertensive Neurological, etc.